(c) 2024 PillSync.com

naratriptan 2.5 mg

1 INDICATIONS AND USAGE Naratriptan is indicated for the acute treatment of migraine attacks with or without aura in adults. Limitations of Use: • Use only if a clear diagnosis of migraine has been established. If a patient has no response to the first migraine attack treated with naratriptan, reconsider the diagnosis of migraine before naratriptan is administered to treat any subsequent attacks. • Naratriptan is not indicated for the prevention of migraine attacks. • Safety and effectiveness of naratriptan have not been established for cluster headache. Naratriptan is a serotonin (5-HT 1B/1D ) receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults. ( 1 ) Limitations of Use: • Use only if a clear diagnosis of migraine has been established. ( 1 ) • Not indicated for the prophylactic therapy of migraine attacks. ( 1 ) • Not indicated for the treatment of cluster headache. ( 1 )

Hikma Pharmaceuticals USA Inc.


10 months ago ROUND WHITE 54 351 naratriptan 2.5 mg

ROUND WHITE 54 351

16 HOW SUPPLIED/STORAGE AND HANDLING

NARATRIPtan Tablets, USP 1 mg tablets are supplied as white to off-white round, biconvex tablets debossed with “54” on one side and “227” on the other side. NDC 0054-0278-03: Bottle of 9 Tablets NDC 0054-0278-25: Bottle of 100 Tablets 2.5 mg tablets are supplied as white to off-white round, biconvex tablets debossed with “54 351” on one side and plain on the other side. NDC 0054-0279-03: Bottle of 9 Tablets NDC 0054-0279-25: Bottle of 100 Tablets Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]


More pills like ROUND 54 351












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site